AinsFac CNS
Key metrics
Earnings
| Revenue, Q3 2026 | ₩2.0bn |
|---|---|
| Revenue QoQ | +118.3% |
| Revenue YoY | +142.5% |
| Operating income, Q3 2026 | -₩1.4bn |
| Operating income QoQ | -21.2% |
| Operating income YoY | +18.2% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩0 |
|---|---|
| Rights offering new shares, last 12 months | 5,868,544 shares |
| Potential new shares, last 12 months | 5,868,544 shares |
| Potential new shares, % of shares | 15.6% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩10.2bn |
|---|---|
| Supply contracts vs prior-year revenue | 212.9% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 41 |
|---|---|
| DART filings, previous 3 months | 15 |
Insider transactions
| Open-market buys, last 12 months (shares) | 146,655 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩132m |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 146,655 shares |
| Insiders who bought, last 12 months | 1 |
Insider transactions (last 12 months)
Open-market buys: 146,655 shares (₩132m). Open-market sells: 0 shares (₩0). Net open-market buying: +146,655 shares. Insiders who bought: 1.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Shin Dong-beom (Registered director) | Open-market buy | +146,655 shares | ₩902 | ₩132m | |
| Sep 29, 2026 | Shin Dong-beom (Registered director) | Other (New appointment) | +3,345 shares | — | — | |
| Sep 28, 2026 | Akeuro Singisuljohap Je241ho (10%+ shareholder) | Other (OTC buy) | +4,782,496 shares | ₩7,100 | ₩34.0bn | |
| Sep 28, 2026 | Ra Mi-ku-seu Co., Ltd. (10%+ shareholder) | Other (OTC sell) | -4,552,496 shares | ₩7,100 | ₩32.3bn | |
| Sep 28, 2026 | Jung Jip-hun (Registered director) | Other (OTC sell) | -230,000 shares | ₩7,100 | ₩1.6bn |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩4.8bn | -₩5.4bn |
| 2024 | ₩25.3bn | -₩9.7bn |
| 2023 | ₩9.9bn | -₩7.0bn |
Filing timeline
-
AinsFac CNS signs ₩5.2bn supply contract with YHT Co., Ltd.
AinsFac CNS filed a supply contract with YHT Co., Ltd. for secondary battery control controller installation and utility hookup, valued at ₩5.2bn. The contract amount is 109.9% of revenue as reported, and the period runs from Oct 1, 2026 to Jul 31, 2027.